Please note that this page may contain information on EMD Serono, Inc. marketed and/or investigational products. Investigational agents and investigational indications for marketed products are under clinical investigation and have not been proven to be safe and effective. There is no guarantee that any product will be approved in the sought-after indication. Please click here to view the full EMD Serono pipeline.
eMedI Chat
eMedI Chat 
NEUROLOGY PIPELINE AGENTS
Cladribine Capsules
Cladribine capsules are under clinical investigation in patients with generalized myasthenia gravis.
- Cladribine capsules EMD Serono Clinical Trial Information
- Cladribine capsules Information at clinicaltrials.gov
Patient Resources
Research
Additional Neurology Resources
This site is intended for US healthcare professionals only.
DISCLAIMER: This site contains medical information that is intended for healthcare providers of the United States only. The medical information contained on this site is not meant to substitute for the advice provided by a medical professional. Canadian residents should consult the EMD Serono Canada Inc. website at www.emdserono.ca for information on products and services approved in Canada. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy.
EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany, in the United States and Canada.
US-MULNP-00046 1/26
© 2026 Merck KGaA, Darmstadt, Germany or its affiliates. All rights reserved.